Bundamedik Tbk Pt Stock Revenue
Bundamedik Tbk PT fundamentals help investors to digest information that contributes to Bundamedik Tbk's financial success or failures. It also enables traders to predict the movement of Bundamedik Stock. The fundamental analysis module provides a way to measure Bundamedik Tbk's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bundamedik Tbk stock.
Bundamedik |
Bundamedik Tbk PT Company Revenue Analysis
Bundamedik Tbk's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Bundamedik Tbk Revenue | 1.71 T |
Most of Bundamedik Tbk's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bundamedik Tbk PT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Bundamedik Tbk PT reported 1.71 T of revenue. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The revenue for all Indonesia stocks is significantly lower than that of the firm.
Bundamedik Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bundamedik Tbk's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bundamedik Tbk could also be used in its relative valuation, which is a method of valuing Bundamedik Tbk by comparing valuation metrics of similar companies.Bundamedik Tbk is currently under evaluation in revenue category among its peers.
Bundamedik Fundamentals
| Return On Equity | 0.0811 | |||
| Return On Asset | 0.0465 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 3.68 T | |||
| Shares Outstanding | 8.6 B | |||
| Shares Owned By Insiders | 78.80 % | |||
| Price To Book | 2.14 X | |||
| Price To Sales | 2.17 X | |||
| Revenue | 1.71 T | |||
| Gross Profit | 799.78 B | |||
| EBITDA | 291.45 B | |||
| Net Income | 215.3 B | |||
| Total Debt | 225.96 B | |||
| Book Value Per Share | 186.41 X | |||
| Cash Flow From Operations | 260.04 B | |||
| Earnings Per Share | 30.71 X | |||
| Target Price | 855.0 | |||
| Number Of Employees | 1.16 K | |||
| Market Capitalization | 3.61 T | |||
| Total Asset | 2.69 T | |||
| Z Score | 9.0 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 2.69 T | |||
| Last Dividend Paid | 2.56 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Tools for Bundamedik Stock
When running Bundamedik Tbk's price analysis, check to measure Bundamedik Tbk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bundamedik Tbk is operating at the current time. Most of Bundamedik Tbk's value examination focuses on studying past and present price action to predict the probability of Bundamedik Tbk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bundamedik Tbk's price. Additionally, you may evaluate how the addition of Bundamedik Tbk to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |